<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03837301</url>
  </required_header>
  <id_info>
    <org_study_id>NCC2018-0162</org_study_id>
    <nct_id>NCT03837301</nct_id>
  </id_info>
  <brief_title>Non-exposure Simple Suturing EFTR (NESS-EFTR) With Laparoscopic Sentinel Lymph Node Navigation for EGC (Senorita3-phase 2)</brief_title>
  <official_title>Non-exposure Simple Suturing Endoscopic Full-Thickness Resection (NESS-EFTR) With Laparoscopic Sentinel Lymph Node Navigation for EGC (Senorita3-phase 2)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Cancer Center, Korea</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Cancer Center, Korea</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Laparoscopic sentinel lymph node dissection and stomach preserving surgery in early gastric
      cancer is less invasive method which can increase quality of life. Current stomach preserving
      surgery after sentinel lymph node dissection produce transmural communication and expose the
      tumor to the peritoneum during operation. An endoscopic full-thickness resection method with
      a simple suturing technique that does not expose the gastric mucosa to the peritoneum
      (non-exposure simple suturing endoscopic full-thickness resection, NESS-EFTR) was recently
      developed.

      This is the phase2 study to identify the efficacy of NESS-EFTR with sentinel node navigation
      in early gastric cancer patients.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 12, 2018</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Anticipated">December 2019</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>complete resection rate (%) of tumor</measure>
    <time_frame>2 weeks</time_frame>
    <description>the definition of complete resection is 'Tumor exist in single resected piece (en bloc resection) with clear resection margin'.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">88</enrollment>
  <condition>Early Gastric Cancer</condition>
  <arm_group>
    <arm_group_label>NESS-EFTR</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Non-exposure Simple Suturing Endoscopic Full-Thickness Resection (NESS-EFTR) With Laparoscopic Sentinel Lymph Node Navigation (basin dissection)</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>NESS-EFTR with sentinel lymph node navigation</intervention_name>
    <description>Non-exposure Simple Suturing Endoscopic Full-Thickness Resection with sentinel lymph node navigation (basin dissection) for early gastric cancer patients</description>
    <arm_group_label>NESS-EFTR</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  single lesion of adenocarcinoma in preoperative endoscopic biopsy

          -  clinical stage T1N0 in the preoperative evaluation of endoscopy and computed
             tomography

          -  tumor size: less than 3cm

          -  location: 3cm far from the pylorus or cardia

          -  aged 20 to 80

          -  ECOG 0 or 1

          -  patient who signed the agreement

          -  patient who is suspected to underwent laparoscopy assisted gastrectomy

        Exclusion Criteria:

          -  absolute indication of endoscopic submucosal resection

          -  inoperable due to poor cardiac, pulmonary function

          -  pregnant

          -  having allergic reaction, previous upper abdominal surgery except laparoscopic
             cholecystectomy, previous radiation therapy to upper abdomen

          -  diagnosed as malignancy within 5 years except carcinoma in situ of cervix cancer and
             thyroid cancer
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Chan G Kim, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>National Cancer Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Chan G Kim, M.D.</last_name>
    <phone>+82319201120</phone>
    <email>glse@ncc.re.kr</email>
  </overall_contact>
  <location>
    <facility>
      <name>National Cancer Center</name>
      <address>
        <city>Goyang</city>
        <zip>10408</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chan G Kim, M.D.</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>February 2019</verification_date>
  <study_first_submitted>February 3, 2019</study_first_submitted>
  <study_first_submitted_qc>February 9, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">February 12, 2019</study_first_posted>
  <last_update_submitted>February 9, 2019</last_update_submitted>
  <last_update_submitted_qc>February 9, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">February 12, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>National Cancer Center, Korea</investigator_affiliation>
    <investigator_full_name>Chan Gyoo Kim</investigator_full_name>
    <investigator_title>M.D.</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stomach Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

